Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...
Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...
The Pill prevents pregnancy -- and maybe ovarian cancer, too, a new study suggests.Women who’ve ever used the contra ...
A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...
The rise of counterfeit fentanyl-laced pharmaceuticals threatens public health. Innovative molecular analytical methods are ...
A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new study.
Your physical environment, social life and lifestyle have as much an influence on your biology − and hence, how you process ...
The Food and Drug Administration (FDA) has approved Journavxâ„¢ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
It’s a little pill with big responsibilities. But despite its primary role to prevent pregnancy, the contraceptive pill (or ...
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback